What is Agios Pharmaceuticals's net investment in lease?

Agios Pharmaceuticals (AGIO) reported net investment in lease of $751K in Q1 2026.

How has Agios Pharmaceuticals's net investment in lease changed year-over-year?

Agios Pharmaceuticals's net investment in lease increased by 129.7% year-over-year, from $327K to $751K.

What is the long-term trend for Agios Pharmaceuticals's net investment in lease?

Over 5 years (2020 to 2025), Agios Pharmaceuticals's net investment in lease has grown at a -18.5% compound annual growth rate (CAGR), from $84.66M to $30.45M.

Agios Pharmaceuticals AGIO Net Investment in Lease

Net Investment in Lease at other companies

Vertex PharmaceuticalsVRTX

——

Disc MedicineIRON

——

PrecigenPGEN

——

CRISPR TherapeuticsCRSP

——

PVL

Palvella TherapeuticsPVLA

——

Aurinia PharmaceuticalsAUPH

——

Other financials

Income statement

See full

Revenue$20.7M+138%

Gross profit$19.4M+154%

Operating income-$110.0M-3.2%

Net income-$99.1M-11.0%

EPS (diluted)-$1.69-9.0%

Balance sheet

See full

Cash & equivalents$113.6M+43.9%

Total debt$35.7M-32.5%

Total equity$1.1B-24.4%

Total assets$1.2B-23.8%

Cash flow

See full

Operating cash flow-$118.9M-6.7%

CapEx$769.0K+0.4%

Free cash flow-$119.7M-6.6%

Valuation

See full

Market cap$2.12B+18.1%

Enterprise value$2.04B+15.2%

P/S32.1×-16.4×

Profitability

See full

Gross margin90%+2.5pp

Operating margin-720%-204pp

Net margin-639.8%—

FCF margin-582.5%-185pp

Returns & leverage

See full

Return on equity-32.8%—

Debt / equity0×0.0×

Current ratio14.2×-4.3×

Where this comes from

Reported directly by Agios Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:LessorOperatingLeasePaymentsToBeReceived.

The official record: Agios Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Agios Pharmaceuticals's net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Agios Pharmaceuticals's net investment in lease?: Agios Pharmaceuticals (AGIO) reported net investment in lease of $751K in Q1 2026.
How has Agios Pharmaceuticals's net investment in lease changed year-over-year?: Agios Pharmaceuticals's net investment in lease increased by 129.7% year-over-year, from $327K to $751K.
What is the long-term trend for Agios Pharmaceuticals's net investment in lease?: Over 5 years (2020 to 2025), Agios Pharmaceuticals's net investment in lease has grown at a -18.5% compound annual growth rate (CAGR), from $84.66M to $30.45M.